The effect of comorbid illness and functional status on the expected benefits of intensive glucose control in older patients with type 2 diabetes: A decision analysis

Annals of Internal Medicine

Volumn 149, Issue 1, 2008, Pages

  Huang, Elbert S ^a   Zhang, Qi ^b   Gandra, Niren ^c   Chin, Marshall H ^a   Meltzer, David O ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b OLD DOMINION UNIVERSITY   (United States)

^c Box 8298 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGED; AMPUTATION; ARTICLE; BLINDNESS; COMORBIDITY; DIABETES CONTROL; DISEASE DURATION; FEMALE; FUNCTIONAL STATUS; GROUPS BY AGE; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MONTE CARLO METHOD; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; QUALITY OF LIFE; UNITED KINGDOM;

EID: 46449117004     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-149-1-200807010-00005     Document Type: Article

References (56)

1. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2005;28 Suppl 1:S4-S36. [PMID: 15618112]
2. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993; 329:977-86. [PMID: 8366922]
3. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998; 352:837-53. [PMID: 9742976]
4. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, et al. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353:2643-53. [PMID: 16371630]
5. Fleming BB, Greenfield S, Engelgau MM, Pogach LM, Clauser SB, Parrott MA. The Diabetes Quality Improvement Project: moving science into health policy to gain an edge on the diabetes epidemic. Diabetes Care. 2001;24:1815-20. [PMID: 11574448]
6. Chin MH, Zhang JX, Merrell K. Specialty differences in the care of older patients with diabetes. Med Care. 2000;38:131-40. [PMID: 10659687]
7. Chin MH, Su AW, Jin L, Nerney MP. Variations in the care of elderly persons with diabetes among endocrinologists, general internists, and geriatricians. J Gerontol A Biol Sci Med Sci. 2000;55:M601-6. [PMID: 11034233]
8. Durso SC. Using clinical guidelines designed for older adults with diabetes mellitus and complex health status. JAMA 2006;295:1935-40. [PMID: 16639053]
9. Abrahamson MJ. A 74-year-old woman with diabetes. JAMA. 2007;297:196-204. [PMID: 17213403]
10. Hayward RA, Hofer TP, Vijan S. Intensive glucose control in elderly adults [Letter]. JAMA 2007;297:2195; author reply 2196. [PMID: 17519406]
11. Brown AF, Mangione CM, Saliba D, Sarkisian CA. California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc. 2003;51:S265-80. [PMID: 12694461]
12. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2004;27 Suppl 1:S15-35. [PMID: 14693923]
13. American Diabetes Association. Standards of medical care in diabetes-2007. Diabetes Care. 2007;30 Suppl 1:S4-S41. [PMID: 17192377]
14. Qaseem A, Vijan S, Snow V, Cross JT, Weiss KB, Owens DK. Clinical Efficacy Assessment Subcommittee of the American College of Physicians. Glycemic control and type 2 diabetes mellitus: the optimal hemoglobin Alc targets. A guidance statement from the American College of Physicians. Ann Intern Med. 2007;147:417-22. [PMID: 17876024]
15. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-83. [PMID: 3558716]
16. Saliba D, Elliott M, Rubenstein LZ, Solomon DH, Young RT, Kamberg CJ, et al. The Vulnerable Elders Survey: a tool for identifying vulnerable older people in the community. J Am Geriatr Soc. 2001;49:1691-9. [PMID: 11844005]
17. Eastman RC, Javitt JC, Herman WH, Dasbach EJ, Copley-Merriman C, Maier W, et al. Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia. Diabetes Care. 1997;20:735-44. [PMID: 9135935]
18. Vijan S, Hofer TP, Hayward RA. Estimated benefits of glycemic control in microvascular complications in type 2 diabetes. Ann Intern Med. 1997;127:788-95. [PMID: 9382399]
19. CDC Diabetes Cost-effectiveness Group. Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes. JAMA 2002;287:2542-51. [PMID: 12020335]
20. Stevens RJ, Kothari V, Adler AI, Stratton IM. United Kingdom Prospective Diabetes Study (UKPDS) Group. The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). Clin Sci (Lond). 2001;101:671-9. [PMID: 11724655].
21. Lee SJ, Lindquist K, Segal MR, Covinsky KE. Development and validation of a prognostic index for 4-year mortality in older adults. JAMA. 2006;295: 801-8. [PMID: 16478903]
22. Eastman RC, Javitt JC, Herman WH, Dasbach EJ, Zbrozek AS, Dong F, et al. Model of complications of NIDDM. I. Model construction and assumptions. Diabetes Care. 1997;20:725-34. [PMID: 9135934]
23. Clarke PM, Gray AM, Briggs A, Farmer AJ, Fenn P, Stevens RJ, et al. UK Prospective Diabetes Study (UKPDS) Group. A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68). Diabetologia. 2004;47:1747-59. [PMID: 15517152]
24. Kothari V, Stevens RJ, Adler AI, Stratton IM, Manley SE, Neil FLA, et al. UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine. Stroke. 2002;33:1776-81. [PMID: 12105351]
25. Mount Hood 4 Modeling Group. Computer modeling of diabetes and its complications: a report on the Fourth Mount Hood Challenge Meeting. Diabetes Care. 2007;30:1638-46. [PMID: 17526823]
26. Huang ES, Zhang Q, Brown SE, Drum ML, Meltzer DO, Chin MH. The cost-effectiveness of improving diabetes care in U.S. federally qualified community health centers. Health Serv Res. 2007;42:2174-93; discussion 2294-323. [PMID: 17995559]
27. Lifetime benefits and costs of intensive therapy as practiced in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group. JAMA. 1996;276:1409-15. [PMID: 8892716]
28. Humphrey LL, Ballard DJ, Frohnert PP, Chu CP, O'Fallon WM, Palumbo PJ. Chronic renal failure in non-insulin-dependent diabetes mellitus. A population-based study in Rochester, Minnesota. Ann Intern Med. 1989;111: 788-96. [PMID: 2817626]
29. Anderson RN, DeTurk PB. United States life tables, 1999. In: National Vital Statistics Reports. Vol. 50, No. 6. Hyattsville, MD: National Center for Health Statistics; 2002. Accessed at www.cdc.gov/nchs/data/nvsr/ nvsr50/nvsr50_06.pdf on 7 May 2008.
30. Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardiovascular disease risk profiles. Am Heart J. 1991;121:293-8. [PMID: 1985385]
31. Hunink MG, Goldman L, Tosteson AN, Mittleman MA, Goldman PA, Williams LW, et al. The recent decline in mortality from coronary heart disease, 1980-1990. The effect of secular trends in risk factors and treatment. JAMA. 1997;277:535-42. [PMID: 9032159]
32. Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO. Survival and recurrence after first cerebral infarction: a population-based study in Rochester, Minnesota, 1975 through 1989. Neurology. 1998;50:208-16. [PMID: 9443482]
33. U.S. Renal Data System. USRDS 1994 Annual Data Report. Bethesda, MD: National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1994:Appendix D17.
34. Robbins JM, Vaccarino V, Zhang H, Kasl SV. Socioeconomic status and type 2 diabetes in African American and non-Hispanic white women and men: evidence from the Third National Health and Nutrition Examination Survey. Am J Public Health. 2001;91:76-83. [PMID: 11189829]
35. Saaddine JB, Cadwell B, Gregg EW, Engelgau MM, Vinicor F, Imperatore G, et al. Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002. Ann Intern Med. 2006;144:465-74. [PMID: 16585660]
36. American Association of Clinical Endocrinologists, American College of Endocrinology. Medical guidelines for the management of diabetes mellitus: the AACE system of intensive diabetes self-management - 2002 update. Endocr Pract. 2002;8(Suppl l):40-82.
37. Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004;291:335-42. [PMID: 14734596]
38. Grant RW, Pirraglia PA, Meigs JB, Singer DE. Trends in complexity of diabetes care in the United States from 1991 to 2000. Arch Intern Med. 2004; 164:1134-9. [PMID: 15159272]
39. Stafford RS, Monti V, Ma J. Underutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease. PLoS Med. 2005;2:e353. [PMID: 16277554]
40. Neumann PJ, Goldie SJ, Weinstein MC. Preference-based measures in economic evaluation in health care. Annu Rev Public Health. 2000;21:587-611. [PMID: 10884966]
41. Dasbach EJ, Fryback DG, Thornbury JR. Health utility preference differences [Abstract]. Med Decis Making. 1992;12:351.
42. Redekop WK, Stolk EA, Kok E, Lovas K, Kalo Z, Busschbach JJ. Diabetic foot ulcers and amputations: estimates of health utility for use in cost-effectiveness analyses of new treatments. Diabetes Metab. 2004;30:549-56. [PMID: 15671925]
43. Ragnarson Tennvall G, Apelqvist J. Prevention of diabetes-related foot ulcers and amputations: a cost-utility analysis based on Markov model simulations. Diabetologia. 2001;44:2077-87. [PMID: 11719840]
44. Rosen AB, Hamel MB, Weinstein MC, Cutler DM, Fendrick AM, Vijan S. Cost-effectiveness of full medicare coverage of angiotensin-converting enzyme inhibitors for beneficiaries with diabetes. Ann Intern Med. 2005;143:89-99. [PMID: 16027450]
45. Huang ES, Shook M, Jin L, Chin MH, Meltzer DO. The impact of patient preferences on the cost-effectiveness of intensive glucose control in older patients with new-onset diabetes. Diabetes Care. 2006;29:259-64. [PMID: 16443870]
46. Naglie G, Krahn MD, Naimark D, Redelmeier DA, Detsky AS. Primer on medical decision analysis: Part 3 - Estimating probabilities and utilities. Med Decis Making. 1997;17:136-41. [PMID: 9107608]
47. Huang ES, Meigs JB, Singer DE. The effect of interventions to prevent cardiovascular disease in patients with type 2 diabetes mellitus. Am J Med. 2001; 111:633-42. [PMID: 11755507]
48. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837-47. [PMID: 9603539]
49. Wolf PA, D'Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham Study. Stroke. 1991;22:312-8. [PMID: 2003301]
50. Geiss LS, Herman WH, Smith PJ. Mortality in non-insulin-dependent diabetes. In: Harris MI, ed. Diabetes in America. Bethesda, MD: National Institute of Health: National Institute of Diabetes and Digestive and Kidney Diseases; 1995:233-58.
51. Arias E. United States life tables, 2003. Natl Vital Stat Rep. 2006;54:1-40. [PMID: 16681183]
52. Hardy SE, Gill TM. Recovery from disability among community-dwelling older persons. JAMA. 2004;291:1596-602. [PMID: 15069047]
53. Huang ES, Brown SE, Ewigman BG, Foley EC, Meltzer DO. Patient perceptions of quality of life with diabetes-related complications and treatments. Diabetes Care. 2007;30:2478-83. [PMID: 17623824]
54. Miller CD, Phillips LS, Ziemer DC, Gallina DL, Cook CB, El-Kebbi IM. Hypoglycemia in patients with type 2 diabetes mellitus. Arch Intern Med. 2001; 161:1653-9. [PMID: 11434798]
55. For safety, NHLBI changes intensive blood sugar treatment strategy in clinical trial of diabetes and cardiovascular disease [News release]. Bethesda, Maryland: National Heart, Lung, and Blood Institute; 6 February 2008. Accessed at public.nhlbi.nih.gov/newsroom/home/GetPressRelease.aspx?id =2551 on 22 February 2008.
56. Major diabetes study does not confirm increased risk of death reported by U.S. trial [News release]. Sydney: The George Institute for International Health; 18 February 2008. Accessed at www.advance-trial.com/static/html/virtual /contents.asp?P=39 on 19 March 2008.